The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
COVID-19 pneumonia: different respiratory treatments for different phenotypes?
Open accessAbstract
The Surviving Sepsis Campaign panel recently recom-mended that “mechanically ventilated patients with COVID-19 should be managed similarly to other patients with acute respiratory failure in the ICU [1].” Yet, COVID-19 pneumonia [2], despite falling in most of the circumstances under the Berlin definition of ARDS [3], is a specific disease, whose distinctive features are severe hypoxemia often associated with near normal respiratory system compliance (more than 50% of the 150 patients measured by the authors and further confirmed by several colleagues in Northern Italy). This remarkable combination is almost never seen in severe ARDS. These severely hypoxemic patients despite sharing a single eti-ology (SARS-CoV-2) may present quite differently from one another: normally breathing (“silent” hypoxemia) or remarkably dyspneic; quite responsive to nitric oxide or not; deeply hypocapnic or normo/hypercapnic; and either responsive to prone position or not. Therefore, the same disease actually presents itself with impressive non-uniformity. Based on detailed observation of several cases and discussions with colleagues treating these patients, we hypothesize that the different COVID-19 patterns found at presentation in the emergency department depend on the interaction between three factors: (1) the severity of the infection, the host response, physiological reserve and comorbidities; (2) the ventilatory responsiveness of the patient to hypoxemia; (3) the time elapsed between the onset of the disease and the observation in the hospital. The interaction between these factors leads to the devel-opment of a time-related disease spectrum within two primary “phenotypes”:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244 · cited 7×
“Yet, COVID-19 pneumonia [2], despite falling in most of the circumstances under the Berlin definition of ARDS [3], is a specific disease, whose distinctive features are severe hypoxemia often associated with near normal respiratory system compliance (more than 50% of the 150 patients measured by the authors and furthe…”
InfluentialAcute Respiratory Distress Syndrome: The Berlin Definition
(2012) · JAMA · doi:10.1001/jama.2012.5669 · Cited by 8,731
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06022-5 · Cited by 2,105
Lung recruitment in patients with the acute respiratory distress syndrome.
Gattinoni, L., Caironi, P., Cressoni, M., Chiumello, D., Ranieri, V. M., Quintel, M., Russo, S., Patroniti, N., Cornejo, R., & Bugedo, G. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052052 · Cited by 1,548
Self-citationMechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure
Brochard, L., Slutsky, A., & Pesenti, A. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201605-1081cp · Cited by 1,274
Gattinoni, L., Pesenti, A., Avalli, L., Rossi, F., & Bombino, M. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.3.730 · Cited by 900
Self-citationVertical gradient of regional lung inflation in adult respiratory distress syndrome.
Pelosi, P., D'Andrea, L., Vitale, G., Pesenti, A., & Gattinoni, L. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.1.8111603 · Cited by 499
Self-citationLung Inhomogeneity in Patients with Acute Respiratory Distress Syndrome
Cressoni, M., Cadringher, P., Chiurazzi, C., Amini, M., Gallazzi, E., Marino, A., Brioni, M., Carlesso, E., Chiumello, D., Quintel, M., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1567oc · Cited by 352
Self-citationRespiratory Drive in Critically Ill Patients. Pathophysiology and Clinical Implications
Vaporidi, K., Akoumianaki, E., Telias, I., Goligher, E. C., Brochard, L., & Georgopoulos, D. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0596so · Cited by 267
Mascheroni, D., Kolobow, T., Fumagalli, R., Moretti, M. P., Chen, V., & Buckhold, D. (1988) · Intensive Care Medicine · doi:10.1007/bf00255628 · Cited by 266
Cited by
Management of COVID-19 Respiratory Distress
Marini, J. J., & Gattinoni, L. (2020) · JAMA · doi:10.1001/jama.2020.6825 · Cited by 1,100
Self-citationEndothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Bonaventura, A., Vecchié, A., Dagna, L., Martinod, K., Dixon, D. L., Van Tassell, B. W., Dentali, F., Montecucco, F., Massberg, S., Levi, M., et al. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00536-9 · Cited by 987
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators (2021) · Intensive Care Medicine · doi:10.1007/s00134-020-06294-x · Cited by 924
Bradley, B. T., Maioli, H., Johnston, R., Chaudhry, I., Fink, S. L., Xu, H., Najafian, B., Deutsch, G., Lacy, J. M., Williams, T., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31305-2 · Cited by 822
Grasselli, G., Tonetti, T., Protti, A., Langer, T., Girardis, M., Bellani, G., Laffey, J., Carrafiello, G., Carsana, L., Rizzuto, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30370-2 · Cited by 694
Nadim, M. K., Forni, L. G., Mehta, R. L., Connor, M. J., Liu, K. D., Ostermann, M., Rimmelé, T., Zarbock, A., Bell, S., Bihorac, A., et al. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00356-5 · Cited by 690
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
Perico, L., Benigni, A., Casiraghi, F., Ng, L. F. P., Renia, L., & Remuzzi, G. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00357-4 · Cited by 607
Large-Scale Multi-omic Analysis of COVID-19 Severity
Overmyer, K. A., Shishkova, E., Miller, I. J., Balnis, J., Bernstein, M. N., Peters-Clarke, T. M., Meyer, J. G., Quan, Q., Muehlbauer, L. K., Trujillo, E. A., et al. (2021) · Cell Systems · doi:10.1016/j.cels.2020.10.003 · Cited by 606
The pathophysiology of ‘happy’ hypoxemia in COVID-19
Dhont, S., Derom, E., Van Braeckel, E., Depuydt, P., & Lambrecht, B. N. (2020) · Respiratory Research · doi:10.1186/s12931-020-01462-5 · Cited by 544
Coagulopathy of Coronavirus Disease 2019
Iba, T., Levy, J. H., Levi, M., Connors, J. M., & Thachil, J. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004458 · Cited by 534
Prone position in ARDS patients: why, when, how and for whom
Guérin, C., Albert, R. K., Beitler, J., Gattinoni, L., Jaber, S., Marini, J. J., Munshi, L., Papazian, L., Pesenti, A., Vieillard-Baron, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06306-w · Cited by 532
Self-citationAcute kidney injury in critically ill patients with COVID-19
Gabarre, P., Dumas, G., Dupont, T., Darmon, M., Azoulay, E., & Zafrani, L. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06153-9 · Cited by 529
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Osuchowski, M. F., Winkler, M. S., Skirecki, T., Cajander, S., Shankar-Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M., Brunkhorst, F. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00218-6 · Cited by 520
Organ-specific manifestations of COVID-19 infection
Gavriatopoulou, M., Korompoki, E., Fotiou, D., Ntanasis-Stathopoulos, I., Psaltopoulou, T., Kastritis, E., Terpos, E., & Dimopoulos, M. A. (2020) · Clinical and Experimental Medicine · doi:10.1007/s10238-020-00648-x · Cited by 502
Polak, S. B., Van Gool, I. C., Cohen, D., von der Thüsen, J. H., & van Paassen, J. (2020) · Modern Pathology · doi:10.1038/s41379-020-0603-3 · Cited by 481
Fan, E., Beitler, J. R., Brochard, L., Calfee, C. S., Ferguson, N. D., Slutsky, A. S., & Brodie, D. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30304-0 · Cited by 473
Jain, V., & Yuan, J.-M. (2020) · International Journal of Public Health · doi:10.1007/s00038-020-01390-7 · Cited by 465
Schmidt, M., Hajage, D., Lebreton, G., Monsel, A., Voiriot, G., Levy, D., Baron, E., Beurton, A., Chommeloux, J., Meng, P., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30328-3 · Cited by 458
Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study
Ziehr, D. R., Alladina, J., Petri, C. R., Maley, J. H., Moskowitz, A., Medoff, B. D., Hibbert, K. A., Thompson, B. T., & Hardin, C. C. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1163le · Cited by 455
Ferrando, C., Suarez-Sipmann, F., Mellado-Artigas, R., Hernández, M., Gea, A., Arruti, E., Aldecoa, C., Martínez-Pallí, G., Martínez-González, M. A., Slutsky, A. S., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06192-2 · Cited by 447
Shekar, K., Badulak, J., Peek, G., Boeken, U., Dalton, H. J., Arora, L., Zakhary, B., Ramanathan, K., Starr, J., Akkanti, B., et al. (2020) · ASAIO Journal · doi:10.1097/mat.0000000000001193 · Cited by 388
Stawicki, S., Jeanmonod, R., Miller, A., Paladino, L., Gaieski, D., Yaffee, A., De Wulf, A., Grover, J., Papadimos, T., Bloem, C., et al. (2020) · Journal of Global Infectious Diseases · doi:10.4103/jgid.jgid_86_20 · Cited by 373
Caputo, N. D., Strayer, R. J., & Levitan, R. (2020) · Academic Emergency Medicine · doi:10.1111/acem.13994 · Cited by 372
Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease
Chitimus, D. M., Popescu, M. R., Voiculescu, S. E., Panaitescu, A. M., Pavel, B., Zagrean, L., & Zagrean, A.-M. (2020) · Biomolecules · doi:10.3390/biom10091211 · Cited by 354
Muralidar, S., Ambi, S. V., Sekaran, S., & Krishnan, U. M. (2020) · Biochimie · doi:10.1016/j.biochi.2020.09.018 · Cited by 346
A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2
Atzrodt, C. L., Maknojia, I., McCarthy, R. D. P., Oldfield, T. M., Po, J., Ta, K. T. L., Stepp, H. E., & Clements, T. P. (2020) · The FEBS Journal · doi:10.1111/febs.15375 · Cited by 341
Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation
Leisman, D. E., Deutschman, C. S., & Legrand, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06059-6 · Cited by 332
Østergaard, L. (2021) · Physiological Reports · doi:10.14814/phy2.14726 · Cited by 315
Botta, M., Tsonas, A. M., Pillay, J., Boers, L. S., Algera, A. G., Bos, L. D. J., Dongelmans, D. A., Hollmann, M. W., Horn, J., Vlaar, A. P. J., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30459-8 · Cited by 289
Chang, R., Elhusseiny, K. M., Yeh, Y.-C., & Sun, W.-Z. (2021) · PLOS ONE · doi:10.1371/journal.pone.0246318 · Cited by 287
Grieco, D. L., Maggiore, S. M., Roca, O., Spinelli, E., Patel, B. K., Thille, A. W., Barbas, C. S. V., de Acilu, M. G., Cutuli, S. L., Bongiovanni, F., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06459-2 · Cited by 286
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
van de Veerdonk, F. L., Netea, M. G., van Deuren, M., van der Meer, J. W., de Mast, Q., Brüggemann, R. J., & van der Hoeven, H. (2020) · eLife · doi:10.7554/elife.57555 · Cited by 284
The Lille COVID-19 ICU and Anatomopathology Group, Copin, M.-C., Parmentier, E., Duburcq, T., Poissy, J., & Mathieu, D. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06057-8 · Cited by 280
Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2
Robba, C., Battaglini, D., Pelosi, P., & Rocco, P. R. M. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1778470 · Cited by 268
Chiumello, D., Busana, M., Coppola, S., Romitti, F., Formenti, P., Bonifazi, M., Pozzi, T., Palumbo, M. M., Cressoni, M., Herrmann, P., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06281-2 · Cited by 261
Self-citationQuah, P., Li, A., & Phua, J. (2020) · Critical Care · doi:10.1186/s13054-020-03006-1 · Cited by 259
Pathogenesis of COVID-19-induced ARDS: implications for an ageing population
Torres Acosta, M. A., & Singer, B. D. (2020) · European Respiratory Journal · doi:10.1183/13993003.02049-2020 · Cited by 247
Bolondi, G., Russo, E., Gamberini, E., Circelli, A., Meca, M. C. C., Brogi, E., Viola, L., Bissoni, L., Poletti, V., & Agnoletti, V. (2020) · World Journal of Emergency Surgery · doi:10.1186/s13017-020-00323-2 · Cited by 82
A rationale for targeting the P2X7 receptor in Coronavirus disease 19
Di Virgilio, F., Tang, Y., Sarti, A. C., & Rossato, M. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15138 · Cited by 71
Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study
Piva, S., DiBlasi, R. M., Slee, A. E., Jobe, A. H., Roccaro, A. M., Filippini, M., Latronico, N., Bertoni, M., Marshall, J. C., & Portman, M. A. (2021) · Respiratory Research · doi:10.1186/s12931-020-01603-w · Cited by 70
Pathways to Severe COVID‐19 for People with Obesity
O’Rourke, R. W., & Lumeng, C. N. (2021) · Obesity · doi:10.1002/oby.23099 · Cited by 42
O'Shea, A., Parakh, A., Hedgire, S., & Lee, S. I. (2021) · American Journal of Roentgenology · doi:10.2214/ajr.20.24132 · Cited by 30
Beyond dexamethasone, emerging immuno‐thrombotic therapies for COVID‐19
Jensen, M. P., George, M., Gilroy, D., & Sofat, R. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14540 · Cited by 17
Metadata
- Authors
- Gattinoni, L., Chiumello, D., Caironi, P., Busana, M., Romitti, F., Brazzi, L., & Camporota, L.
- Venue
- Intensive Care Medicine
- Published
- 2020-04-14
- Volume
- 46
- Issue
- 6
- Pages
- 1099-1102
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W3015269808
- Cited by
- 1,852
- References
- 17
- FWCI
- 208.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.